A record linkage study of outcomes in patients with mild primary hyperparathyroidism: The Parathyroid Epidemiology and Audit Research Study (PEARS)
Authors:
- 6 July 2011
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 75 (2) , 169-176
Abstract
Primary hyperparathyroidism (PHPT) is a common endocrine disorder, but the majority of cases are perceived to be mild and remain untreated. To determine the risk of mortality and morbidities in patients with mild PHPT. Tayside, Scotland, 1997-2006. A historical, prospective, record-linkage, population-based, matched cohort study. All patients with diagnosed but untreated, mild PHPT. METHOD AND OUTCOME MEASURES: Each patient with PHPT was matched with five population-based comparators, by age, gender and calendar year of PHPT diagnosis, selected from the general population. Primary outcomes were all-cause mortality, fatal and nonfatal cardiovascular disease (CVD). Secondary outcomes were cancer-related deaths and other hospital admitted morbidities, including cerebrovascular disease, fractures, hypertension, psychiatric disease, renal complications, cancer and diabetes. The risk was assessed using the Cox proportional hazards model, adjusting for confounding factors of pre-existing co-morbidities, previous prescription of bisphosphonates, socio-economic deprivation score and the probability of having a calcium check. Compared to the matched cohort, the risk of all cause mortality, fatal and nonfatal CVD was increased in patients with asymptomatic PHPT: adjusted hazard ratios (HR) 1·64 (95% CI: 1·43-1·87), 1·64 (95% CI: 1·32-2·04) and 2·48 (95% CI: 2·13-2·89), respectively. The risk was also increased in all secondary outcomes, with the risk of renal failure and renal stones being the highest, adjusted HRs being 13·83 (95% CI: 10·41-18·37) and 5·15 (95% CI: 2·69-9·83), respectively. Patients with mild PHPT had an increased risk of mortality, fatal and nonfatal CVD, and the risk of developing other co-morbidities was also increased.Keywords
This publication has 22 references indexed in Scilit:
- Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International WorkshopThe Journal of Clinical Endocrinology & Metabolism, 2009
- Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International WorkshopThe Journal of Clinical Endocrinology & Metabolism, 2009
- Increased Mortality in Patients Hospitalized with Primary Hyperparathyroidism during the Period 1977–1993 in DenmarkWorld Journal of Surgery, 2003
- Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st CenturyThe Journal of Clinical Endocrinology & Metabolism, 2002
- Cardiovascular disease, hypertension and renal function in primary hyperparathyroidismJournal of Internal Medicine, 2002
- Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 yearsSurgery, 2001
- Increased risk of death from primary hyperparathyroidism — an updateEuropean Journal of Clinical Investigation, 1998
- Survival after the Diagnosis of Hyperparathyroidism: A Population-based StudyThe American Journal of Medicine, 1998
- Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism: Consensus Development Conference StatementAnnals of Internal Medicine, 1991
- SURVIVAL AND RENAL FUNCTION IN UNTREATED HYPERCALCAEMIAThe Lancet, 1987